Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Tuberculosis Testing Market, Size, Share, Opportunities and Forecast, 2020-2027

Published by DataM Intelligence Product code 955344
Published Content info 180 Pages
Delivery time: 2 business days
Price
Back to Top
Global Tuberculosis Testing Market, Size, Share, Opportunities and Forecast, 2020-2027
Published: April 3, 2021 Content info: 180 Pages
Description

Global Tuberculosis Testing Market is segmented By Test Type (NuсlеIс АсId ТеstIng, Cytokine Detection Assay, Detection of Latent Infection, Сulturе Ваsеd Теsts, Drug SusсерtIbIlItу ТеstIng, others), By End-User (Hospital laboratories, Research laboratories, Clinics laboratories, Diagnostic center), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis, 2020-2027

Market Overview

Global Tuberculosis Testing Market is expected to grow at a high CAGR of 5.2% during the forecasting period (2020-2027).

Tuberculosis (TB) is a communicable disease that is a major cause of ill health, one of the top 10 causes of death worldwide, and the leading cause of death from a single infectious agent. It is caused by the bacillus Mycobacterium tuberculosis, which is spread when sick people with TB expel bacteria into the air, for example, by coughing. It typically affects the lungs (pulmonary TB) but can also affect other sites. About a quarter of the world's population is infected with M. tuberculosis and thus at risk of developing TB disease. Tuberculosis testing can be defined as the most commonly used diagnostic tool for tuberculosis. With a timely diagnosis and treatment with first-line antibiotics for 6 months, most people who develop TB can be cured, and onward transmission of infection curtailed. The number of TB cases occurring each year can also be driven down by reducing the prevalence of health-related risk factors for TB providing preventive treatment to people.

  • Source: DataM Intelligence Analysis 

Market Dynamics:

The market is driven by the increasing number of coronavirus cases, increasing the number of tuberculosis patients.  According to the World Health Organization (WHO), in 2017, an estimated 4.4 million people fell ill with TB, and an estimated 638,000 died because of the disease, which is more than half of global TB deaths. Factors propelling the market's growth include the increasing burden of tuberculosis and multidrug-resistant tuberculosis, increasing R&D investments, intensive product pipelines, and increasing government initiatives in the emerging markets. The landscape of TB diagnostics has changed dramatically during the past ten years. Moreover, in response to the WHO Global TB program, it has implemented a systematic and dynamic process used to evaluate technologies and develop policies, which has enhanced the market's growth.

The prevalence rate of tuberculosis is also increasing every year, along with the number of government awareness programs that influence people to opt for diagnostic tests (like radiographic tests), which are expected to drive the market during the forecast period. The market is also expected to witness growth as there is an opportunity for players in the market to accelerate their pipeline diagnostic products' market approval by spurring the fundamental research in TB. Additionally, technological developments in genomics and proteomics can be leveraged by diagnostic providers to hasten product development in TB diagnostics.

The increasing screening rate in the high burden regions, affordability of diagnostics, advanced methodologies, faster clinical decisions, and reduction in mortality rate are the focal areas of development. Improved preventive and curative diagnosis rates are the results of these initiatives. This has led to a subsequent upsurge in demand for diagnostic tests and the TB diagnostics market.

Furthermore, the government and independent healthcare organizations have undertaken initiatives to control this infectious disease's proliferation. Creating awareness about the importance of diagnosis is vital in increasing the screening and diagnosis rates, further helping the TB diagnostics market flourish. This factor is driving the growth of the market in the forecast period. For instance, the Revised National Tuberculosis Control Program (RNTCP) in India focuses on performing TB screening and providing greater access to treatment through free diagnosis & treatment programs. Besides, private-public partnerships under this program are boosting the diagnosis rate.

Population above the age of 60 is the target population for the TB diagnostics market as this demographic is susceptible to infectious diseases. The growing geriatric population base, as a result, is driving the growth of the market.

However, drug resistance in tuberculosis is one of the primary concerns for healthcare professionals as improper treatment due to wrong drug regimens and incorrect dosage forms lead to drug resistance in TB patients undergoing treatment, restraining the market's growth.

Segment Analysis

The global tuberculosis testing market is segmented on test type by Cytokine Detection Assay, NuсlеIс АсId ТеstIng, Detection of Latent Infection, Сulturе Ваsеd Теsts, Drug SusсерtIbIlItу ТеstIng, and Оthеrs. The NuсlеIс АсId ТеstIng segment held the largest market share due to its use as diagnostic tools for tuberculosis (TB) for many years, and which continue to be used. There are substantial advancements in the diagnosis of TB. Moreover, these tests have been commercially available in the United States for over two decades that offer better accuracy than other microscopy tests and even provide greater speed than culture-based tests. A nucleic acid test for tuberculosis (TB) is a molecular test used to detect the DNA (deoxyribonucleic acid) of Mycobacterium tuberculosis complex (MTBC) in sputum or other respiratory samples. Because the amount of DNA in a sample is minimal, NAA testing includes a step that amplifies (or copies) the genetic material. Polymerase Chain Reaction (PCR) is a common form of nucleic acid test used in laboratory diagnosis.

Drug SusсерtIbIlItу ТеstIng is expected to have positive market growth because they are cost-efficient and easy-to-perform. The high burden regions rely on these methodologies due to their financial and technical incapability to incorporate advanced technologies, thus contributing to its growth.

A Cytokine Detection Assay is usually employed to check for the specific cytokines being secreted. This is more a function of biochemistry research rather than a specific test for body functions. Cytokines and their receptors are under a great deal of research because of their role in disease control. It is worth noting that many cytokines have an opposing and sometimes complementary effect on each other; thereby, modulating the immune response's severity. Cytokine assays are used to identify which cytokines and their deficiencies are responsible for the cause of some autoimmune diseases.

A Detection of Latent Infection The goal of testing for LTBI is to identify individuals at increased risk for developing tuberculosis (TB) and, therefore, who would benefit from treatment of latent TB infection. Only those who would benefit from treatment should be tested, so a decision to test presupposes a decision to treat if the test is positive. This factor would drive the growth of the market in the forecast period.

According to WHO, in 2018, globally, 65 countries reported initiating TB preventive treatment for 1.8 million people from just under 1 million in 2017. The 2018 number suggests that 6 million people in the period 2018-2022 can be achieved.  Funding for TB prevention, diagnostic and treatment services has doubled since 2006 but still falls far short of what is needed.

  • *Source: DataM Intelligence Analysis

Further, the market is also classified based on End-User as Hospital laboratories, Research laboratories, Clinics laboratories, Diagnostic centers. The hospital laboratories segment accounts for the highest market share due to the cost of effective tests available in hospitals. As per the CDC, around 9.105 TB cases (2.8 cases per 100,000 persons) were suffering from TB in 2017. In 2017 only a total of 1600,000 deaths were reported due to TB. After this increasing number of TB patients all over the world, the demand for hospitals is increasing. Each hospital laboratory manages its own purchase tender for large equipment purchases and at the lab manager's discretion for smaller purchases. Each hospital lab has a global budget. There is no fee for service. This factor drives the growth of the market in the forecast period.

The clinic's laboratories have positive growth during the forecast period. The primary need is for simple confirmatory or screening tests for use in clinics to distinguish active tuberculosis from all other conditions that may cause the same symptoms. Tests are also needed to monitor treatment response, determine whether there is the bacterial resistance to specific drugs, and detect latent infection in people at greatest risk for progression to active TB following exposure. In rural settings and smaller clinic laboratories, human and financial resource limitations render the implementation of sophisticated technologies impossible, even if they are otherwise attractive. However, these smaller clinic's laboratory on the periphery of the health system is where most TB suspects initially seek care. These factors are driving the growth of the market in the forecast period.

  • *Source: DataM Intelligence Analysis

Geographical Presentation

The global tuberculosis testing market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, Asia-Pacific dominated the global tuberculosis testing market and is expected to grow at the highest CAGR during the forecast period. The growth of the market in the region is attributed to tuberculosis's high burden and the rapid proliferation of this disease. The increasing prevalence of TB in Japan helps in the TB diagnostics market's growth. The high prevalence of TB creates an urgent demand for effective and quick diagnosis of the disease. Besides, in countries such as India, according to the recent budget announcement, the Government of India aims to eliminate tuberculosis by 2025, which is expected to act as one of the major factors for the growth of the Asia-Pacific market forecast period.

Infectious and Endemic Disease Control in China, RNTCP in India, and the National TB program in Afghanistan are the few programs planned by local healthcare agencies to contain the incidence and ensure equitable access to diagnosis. As per the WHO, countries such as India, China, Afghanistan, and Indonesia are priority regions for controlling this communicable disease.

The Middle East and Africa region are expected to have the third-largest share due to the relatively faster pace because of the increasing instances of tuberculosis. The increasing government focuses on establishing regulations to approve tuberculosis tests and growing focus on awareness programs by the tuberculosis diagnosis testing kits manufacturing companies. North America, powered by the U.S., is one of the major markets for the global tuberculosis testing market.

In October 2018, BD, a leading global medical technology company, announced the BD MAX™ MDR-TB panel availability in Europe. BD launched the first automated liquid culture system, the BD BACTEC™ MGIT™ system, for comprehensive drug susceptibility and resistance testing.

  • *Source: DataM Intelligence Analysis

Competitive Analysis

The global tuberculosis testing market is highly competitive, with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition. Thermo Fisher Scientific, Inc., Hologic Corporation, Abbott Laboratories, Alere, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, bioMerieux SA, Sanofi, Cepheid, Hain Lifescience GmbH, are the leading market players with significant market share. The major players are using product development, novel product launches, market expansion, and product diversification strategies for holding their position in the market.

The companies are entering into collaborations, mergers, strategic partnerships, and acquisitions to expand their presence and meet the rising demand for the Treatment of COVID-19 across the globe.

For instance, in July 2016, bioMerieux launched a novel CE-marked database and reagents kit VITEK MS to identify TB. This new product launch is anticipated to help the company increase its market share.

In September 2017, Thermo Fisher Scientific, Inc. acquired Alfa Aesar for USD 400 million. Alfa Aesar is involved in providing laboratory and research chemicals ranging from catalysts, reagents, analytical, and labeling products. Their combined strength in laboratory chemical development and production is expected to support their growth in this sector.

Why Purchase the Report?

Visualize the composition of the global tuberculosis testing market products in terms of test type, and End User and highlight critical commercial assets and players.  

Identify commercial opportunities in the global tuberculosis testing market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global tuberculosis testing market-level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

  • *The global tuberculosis testing market report will provide access to approximately 63 market data tables, 38 figures, and 200 pages

Target Audience2022

Industry Investors/Investment Bankers

Suppliers/Buyers

Education & Research Institutes

Manufacturers

Research Professionals

Emerging Companies

Distributors

Related Topic's

Tuberculosis Drug Market

Tuberculosis - Pipeline Insight

Table of Contents

Table of Contents

Table of Contents

Global Tuberculosis Testing Market Methodology and Scope

Research Methodology

Research Objective and Scope of the Report

Global Tuberculosis Testing Market - Market Definition and Overview

Global Tuberculosis Testing Market- Executive Summary

Market Snippet by Test Type

Market Snippet by End User

Market Snippet by Region

Global Tuberculosis Testing Market Dynamics

Market Impacting Factors

Drivers

The increasing burden of tuberculosis and multidrug-resistant Tuberculosis

Increasing government initiatives and rising awareness in the emerging market

 Restraints

High costs associated with tuberculosis diagnostics

Resistance to the TB medicines

Impact Analysis

Opportunity

Global Tuberculosis Testing Market - Industry Analysis

Porter's Five Forces Analysis

Supply Chain Analysis

Regulatory Analysis

Pricing Analysis

Product Analysis

Industry Value Chain Analysis

Global Tuberculosis Testing Market - By Test Type

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test  Type

Market Attractiveness Index, By Test Type

NuсlеIс АсId ТеstIng*

Introduction

Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027

Cytokine Detection Assay

Detection of Latent Infection

Сulturе Ваsеd Теsts

Drug SusсерtIbIlItу ТеstIng

Others

Global Tuberculosis Testing Market - By End-User

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.

Market Attractiveness Index, By End User

Hospital laboratories*

Introduction

Market Size Analysis, USD Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2027

Research laboratories

Clinics laboratories

Diagnostic center

Global Tuberculosis Testing Market - By Region

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

Market Attractiveness Index, By Region

North America*

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

The U.S.

Canada

Mexico

Europe

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Germany

The U.K.

France

Rest of Europe

South America

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Brazil

Argentina

Rest of South America

Asia Pacific

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

China

India

Japan

Australia

Rest of Asia Pacific

The Middle East and Africa

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.

 Global Tuberculosis Testing Market Competitive Landscape

Competitive Scenario

Market Positioning/Share Analysis

Mergers and Acquisitions Analysis

Global Tuberculosis Testing Market Company Profiles

Thermo Fisher Scientific, Inc. *

Company Overview

Product Portfolio and Description

Key Developments

Financial Overview

Hologic Corporation

 Abbott Laboratories

 Alere, Inc.

Lupin Pharmaceuticals, Inc.

 Becton, Dickinson and Company

 F. Hoffmann-La Roche AG

 bioMerieux SA

 Sanofi.

 Cepheid (*List is not exhaustive)

Global Tuberculosis Testing Market - Premium Insights

Global Tuberculosis Testing Market - DataM

Appendix

About Us and Services

Contact Us

Back to Top